Cargando…
TRAF2 as a key candidate gene in clinical hepatitis B-associated liver fibrosis
Objectives: Approximately 240 million individuals are infected with chronic hepatitis B virus (HBV) worldwide. HBV infection can develop into liver fibrosis. The mechanism of HBV-related liver fibrosis has not been fully understood, and there are few effective treatment options. The goal of this stu...
Autores principales: | Wu, Cichun, Zhang, Jian, Wang, Huiwen, Zhang, Wei, Liu, Jingqing, Zhou, Nianqi, Chen, Keyu, Wang, Ying, Peng, Shifang, Fu, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113534/ https://www.ncbi.nlm.nih.gov/pubmed/37091870 http://dx.doi.org/10.3389/fmolb.2023.1168250 |
Ejemplares similares
-
Identification of AKR1B10 as a key gene in primary biliary cholangitis by integrated bioinformatics analysis and experimental validation
por: Wang, Huiwen, et al.
Publicado: (2023) -
Glutamate-Cysteine Ligase Catalytic Subunit Attenuated Hepatitis C Virus-Related Liver Fibrosis and Suppressed Endoplasmic Reticulum Stress
por: Fu, Na, et al.
Publicado: (2020) -
Nanotechnology in Drug Delivery for Liver Fibrosis
por: Gu, Lihong, et al.
Publicado: (2022) -
Novel Therapeutic Targets in Liver Fibrosis
por: Zhang, Jinhang, et al.
Publicado: (2021) -
Immune and Metabolic Alterations in Liver Fibrosis: A Disruption of Oxygen Homeostasis?
por: Li, Xinyu, et al.
Publicado: (2022)